The news: OpenLoop Health, a provider of back-end infrastructure for telehealth brands, rolled out Launchpad, a new offering that the company says can get a virtual care platform up and running in as little as 24 hours.

OpenLoop already manages back-end essentials like medical staffing and provider credentialing. Launchpad adds the consumer-facing layer, such as patient storefronts and scheduling systems, to compress the traditional launch timeline. According to the company, these new components can be deployed in as little as one day, with full go-lives possible within a few days.

Why it matters: Launchpad is built for transactional care, but not continuous care. OpenLoop’s offerings appear to fit telehealth models focused on prescription treatment access and episodic care rather than ongoing clinical relationships. That shows in the treatment categories Launchpad is initially targeting: weight loss, erectile dysfunction, hair loss, hormone therapy, and longevity care. These are all high-demand treatment areas where patients want a prescription fast.

This transactional, outsourced telehealth model OpenLoop is built to scale has already stoked fears about patient safety and continuity of care. Clinicians working through white-label telehealth platforms likely lack access to a patient’s full medical history and might not even know which telehealth company referred the patient, as OpenLoop serves multiple telehealth brands and physicians are often contracted through affiliated services rather than individual companies, per STAT.

An ongoing lawsuit against OpenLoop and compounding pharmacy Triad Rx accuses the companies of deceiving patients into buying unapproved and ineffective weight loss treatments. Further, critics have slammed telehealth companies that are powered by OpenLoop’s platform for allowing consumers to manipulate their weight information to generate prescription eligibility.

Implications for telehealth brands: Telehealth “in a box” offers an appealing path to expanding care online, but it is also a liability. The same shortcuts that compress a build from months to days also compress the diligence behind clinical oversight. Digital health startups may be tempted to launch quickly, but doing so without rigorous partner vetting and operational safeguards risks regulatory scrutiny, eroded trust, and lawsuits, like the one OpenLoop is already facing. Convenience cannot be a substitute for a legitimate doctor-patient relationship.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.